Magnetic resonance imaging of the liver: Sequence optimization and artifacts

Magnetic Resonance Imaging Clinics of North America

Volumn 18, Issue 3, 2010, Pages 525-547

  Wile, Geoffrey E ^a   Leyendecker, John R ^b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

1.5 T imaging protocol; Imaging artifacts; Liver; Sequence optimization

Indexed keywords

GADOBENIC ACID; GADOBUTROL; GADOLINIUM; GADOXETIC ACID; MANGAFODIPIR; SUPERPARAMAGNETIC IRON OXIDE;

ARTIFACT; BREATH HOLDING; BREATHING MECHANICS; CALIBRATION; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; ELECTRON SPIN RESONANCE; FATTY LIVER; FLUOROSCOPY; HEPATOGRAPHY; HUMAN; IMAGE DISPLAY; IMAGE PROCESSING; IMAGE QUALITY; IMAGE RECONSTRUCTION; LIVER ADENOMA; LIVER CANCER; LIVER CELL CARCINOMA; LIVER CIRCULATION; LIVER CIRRHOSIS; LIVER CYST; LIVER DISEASE; LIVER HEMANGIOMA; LIVER HYPERPLASIA; LIVER METASTASIS; LYMPHOMA; METASTASIS POTENTIAL; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIOFREQUENCY; RADIOLOGICAL PARAMETERS; REVIEW; SIGNAL NOISE RATIO; THREE DIMENSIONAL IMAGING;

ALGORITHMS; ARTIFACTS; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LIVER; MAGNETIC RESONANCE IMAGING; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 78649305955     PISSN: 10649689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mric.2010.07.010     Document Type: Review

References (96)

1. Lattanzi R., Sodickson D.K., Grant A.K., et al. Electrodynamic constraints on homogeneity and radiofrequency power deposition in multiple coil excitations. Magn Reson Med 2009, 61(2):315-334.
2. Merkle E.M., Dale B.M. Abdominal MRI at 3.0 T: the basics revisited. Am J Roentgenol 2006, 186(6):1524-1532.
3. Kataoka M., Isoda H., Maetani Y., et al. MR imaging of the female pelvis at 3 Tesla: evaluation of image homogeneity using different dielectric pads. J Magn Reson Imaging 2007, 26(6):1572-1577.
4. Roemer P.B., Edelstein W.A., Hayes C.E., et al. The NMR phased array. Magn Reson Med 1990, 16(2):192-225.
5. Hoult D.I., Chen C.N., Sank V.J. Quadrature detection in the laboratory frame. Magn Reson Med 1984, 1(3):339-353.
6. Du Y.P., Parker D.L., Davis W.L., et al. Reduction of partial-volume artifacts with zero-filled interpolation in 3-dimensional MR-angiography. JMRI 1994, 4(5):733-741.
7. Sodickson D.K., Hardy C.J., Zhu Y.D., et al. Rapid volumetric MRI using parallel imaging with order-of-magnitude accelerations and a 32-element RF coil array: feasibility and implications. Acad Radiol 2005, 12(5):626-635.
8. Elgavish R.A., Twieg D.B. Improved depiction of small anatomic structures in MR images using Gaussian-weighted spirals and zero-filled interpolation. Magn Reson Imaging 2003, 21(2):103-112.
9. Bammer R., Schoenberg S.O. Current concepts and advances in clinical parallel magnetic resonance imaging. Top Magn Reson Imaging 2004, 15(3):129-158.
10. Sodickson D.K., Manning W.J. Simultaneous acquisition of spatial harmonics (SMASH): fast imaging with radiofrequency coil arrays. Magn Reson Med 1997, 38(4):591-603.
11. Pruessmann K.P., Weiger M., Scheidegger M.B., et al. Sense: sensitivity encoding for fast MRI. Magn Reson Med 1999, 42(5):952-962.
12. Yang R.K., Roth C.G., Ward R.J., et al. Optimizing abdominal MR imaging: approaches to common problems. Radiographics 2010, 30(1):185-U210.
13. Glockner J.F., Hu H.H., Stanley D.W., et al. Parallel MR imaging: a user's guide. Radiographics 2005, 25(5):1279-1297.
14. Rescinito G., Sirlin C., Cittadini G. Body MRI artefacts: from image degradation to diagnostic utility. Radiol Med 2009, 114(1):18-31.
15. Wood M.L., Runge V.M., Henkelman R.M. Overcoming motion in abdominal MR imaging. Am J Roentgenol 1988, 150(3):513-522.
16. Chavhan G.B., Babyn P.S., Jankharia B.G., et al. Steady-state MR imaging sequences: physics, classification, and clinical applications. Radiographics 2008, 28(4):1147-1160.
17. Keogan M.T., Edelman R.R. Technologic advances in abdominal MR imaging. Radiology 2001, 220(2):310-320.
18. Dutka M.V., Bergin D., O'Kane P.L., et al. Rapid multiplanar abdominal survey using MRI with the steady-state free-precession technique. J Magn Reson Imaging 2008, 27(1):198-203.
19. Babcock E.E., Brateman L., Weinreb J.C., et al. Edge artifacts in MR images: chemical shift effect. J Comput Assist Tomogr 1985, 9(2):252-257.
20. Ito K., Mitchell D.G., Matsunaga N. MR imaging of the liver: techniques and clinical applications. Eur J Radiol 1999, 32(1):2-14.
21. Mortele K.J., Praet M., Van Vlierberghe H., et al. CT and MR imaging findings in focal nodular hyperplasia of the liver: radiologic-pathologic correlation. AJR Am J Roentgenol 2000, 175(3):687-692.
22. Merkle E.M., Nelson R.C. Dual gradient-echo in-phase and opposed-phase hepatic MR imaging: a useful tool for evaluating more than fatty infiltration or fatty sparing. Radiographics 2006, 26(5):1409-1418.
23. Dixon W.T. Simple proton spectroscopic imaging. Radiology 1984, 153(1):189-194.
24. Glover G.H., Schneider E. Three-point Dixon technique for true water/fat decomposition with B0 inhomogeneity correction. Magn Reson Med 1991, 18(2):371-383.
25. Ma J. Dixon techniques for water and fat imaging. J Magn Reson Imaging 2008, 28(3):543-558.
26. Low R.N., Ma J.F., Panchal N. Fast spin-echo triple-echo Dixon: initial clinical experience with a novel pulse sequence for fat-suppressed T2-weighted abdominal MR imaging. J Magn Reson Imaging 2009, 30(3):569-577.
27. Saranathan M., Rettmann D., Bayram E., et al. Multiecho time-resolved acquisition (META): a high spatiotemporal resolution Dixon imaging sequence for dynamic contrast-enhanced MRI. J Magn Reson Imaging 2009, 29(6):1406-1413.
28. Kondo H., Kanematsu M., Itoh K., et al. Does T2-weighted MR imaging improve preoperative detection of malignant hepatic tumors? Observer performance study in 49 surgically proven cases. Magn Reson Imaging 2005, 23(1):89-95.
29. Hussain H.K., Syed I., Nghiem H.V., et al. T2-weighted MR imaging in the assessment of cirrhotic liver. Radiology 2004, 230(3):637-644.
30. Masui T., Katayama M., Kobayashi S., et al. T2-weighted MRI of the female pelvis: comparison of breath-hold fast-recovery fast spin-echo and nonbreath-hold fast spin-echo sequences. J Magn Reson Imaging 2001, 13(6):930-937.
31. Augui J., Vignaux O., Argaud C., et al. Liver: T2-weighted MR imaging with breath-hold fast-recovery optimized fast spin-echo compared with breath-hold half-Fourier and non-breath-hold respiratory-triggered fast spin-echo pulse sequences. Radiology 2002, 223(3):853-859.
32. Lee S.S., Byun J.H., Hong H.S., et al. Image quality and focal lesion detection on T2-weighted MR imaging of the liver: comparison of two high-resolution free-breathing imaging techniques with two breath-hold imaging techniques. J Magn Reson Imaging 2007, 26(2):323-330.
33. Kanematsu M., Hoshi H., Itoh K., et al. Focal hepatic lesion detection: comparison of four fat-suppressed T2-weighted MR imaging pulse sequences. Radiology 1999, 211(2):363-371.
34. Lu D.S., Saini S., Hahn P.F., et al. T2-weighted MR imaging of the upper part of the abdomen: should fat suppression be used routinely?. AJR Am J Roentgenol 1994, 162(5):1095-1100.
35. Delfaut E.M., Beltran J., Johnson G., et al. Fat suppression in MR imaging: techniques and pitfalls. Radiographics 1999, 19(2):373-382.
36. Lauenstein T.C., Sharma P., Hughes T., et al. Evaluation of optimized inversion-recovery fat-suppression techniques for T2-weighted abdominal MR imaging. J Magn Reson Imaging 2008, 27(6):1448-1454.
37. Hirokawa Y., Isoda H., Maetani Y.S., et al. MRI artifact reduction and quality improvement in the upper abdomen with PROPELLER and prospective acquisition correction (PACE) technique. AJR Am J Roentgenol 2008, 191(4):1154-1158.
38. Nanko S., Oshima H., Watanabe T., et al. Usefulness of the application of the BLADE technique to reduce motion artifacts on navigation-triggered prospective acquisition correction (PACE) T2-weighted MRI (T2WI) of the liver. J Magn Reson Imaging 2009, 30(2):321-326.
39. Hirokawa Y., Isoda H., Maetani Y.S., et al. Hepatic lesions: improved image quality and detection with the periodically rotated overlapping parallel lines with enhanced reconstruction technique. Evaluation of SPIO-enhanced T2-weighted MR images. Radiology 2009, 251(2):388-397.
40. Bayramoglu S., Kilickesmez O., Cimilli T., et al. T2-weighted MRI of the upper abdomen: comparison of four fat-suppressed T2-weighted sequences including PROPELLER (BLADE) technique. Acad Radiol 2010, 17(3):368-374.
41. Martin D.R., Semelka R.C. Magnetic resonance imaging of the liver: review of techniques and approach to common diseases. Semin Ultrasound CT MR 2005, 26(3):116-131.
42. Hecht E.M., Holland A.E., Israel G.M., et al. Hepatocellular carcinoma in the cirrhotic liver: gadolinium-enhanced 3D T1-weighted MR imaging as a stand-alone sequence for diagnosis. Radiology 2006, 239(2):438-447.
43. Coulam C.H., Chan F.P., Li K.C. Can a multiphasic contrast-enhanced three-dimensional fast spoiled gradient-recalled echo sequence be sufficient for liver MR imaging?. AJR Am J Roentgenol 2002, 178(2):335-341.
44. Seale M.K., Catalano O.A., Saini S., et al. Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree. Radiographics 2009, 29(6):1725-1748.
45. Rofsky N.M., Lee V.S., Laub G., et al. Abdominal MR imaging with a volumetric interpolated breath-hold examination. Radiology 1999, 212(3):876-884.
46. Lee V.S., Lavelle M.T., Rofsky N.M., et al. Hepatic MR imaging with a dynamic contrast-enhanced isotropic volumetric interpolated breath-hold examination: feasibility, reproducibility, and technical quality. Radiology 2000, 215(2):365-372.
47. Goshima S., Kanematsu M., Kondo H., et al. Optimal acquisition delay for dynamic contrast-enhanced MRI of hypervascular hepatocellular carcinoma. Am J Roentgenol 2009, 192(3):686-692.
48. Van Beers B.E., Materne R., Lacrosse M., et al. MR imaging of hypervascular liver tumors: timing optimization during the arterial phase. J Magn Reson Imaging 1999, 9(4):562-567.
49. Sharma P., Kitajima H.D., Kalb B., et al. Gadolinium-enhanced imaging of liver tumors and manifestations of hepatitis: pharmacodynamic and technical considerations. Top Magn Reson Imaging 2009, 20(2):71-78.
50. Earls J.P., Rofsky N.M., DeCorato D.R., et al. Hepatic arterial-phase dynamic gadolinium-enhanced MR imaging: optimization with a test examination and a power injector. Radiology 1997, 202(1):268-273.
51. Materne R., Horsmans Y., Jamart J., et al. Gadolinium-enhanced arterial-phase MR imaging of hypervascular liver tumors: comparison between tailored and fixed scanning delays in the same patients. J Magn Reson Imaging 2000, 11(3):244-249.
52. Elsayes K.M., Narra V.R., Yin Y., et al. Focal hepatic lesions: diagnostic value of enhancement pattern approach with contrast-enhanced 3D gradient-echo MR imaging. Radiographics 2005, 25(5):1299-1320.
53. Martin D.R., Semelka R.C. Imaging of benign and malignant focal liver lesions. Magn Reson Imaging Clin N Am 2001, 9(4):785-802. vi-vii.
54. Quillin S.P., Atilla S., Brown J.J., et al. Characterization of focal hepatic masses by dynamic contrast-enhanced MR imaging: findings in 311 lesions. Magn Reson Imaging 1997, 15(3):275-285.
55. Shen X.Y., Chai C.H., Xiao W.B., et al. Diagnostic value of the fluoroscopic triggering 3D LAVA technique for primary liver cancer. Hepatobiliary Pancreat Dis Int 2010, 9(2):159-163.
56. Kanematsu M., Semelka R.C., Matsuo M., et al. Gadolinium-enhanced MR imaging of the liver: optimizing imaging delay for hepatic arterial and portal venous phases-a prospective randomized study in patients with chronic liver damage. Radiology 2002, 225(2):407-415.
57. Martin D.R., Seibert D., Yang M., et al. Reversible heterogeneous arterial phase liver perfusion associated with transient acute hepatitis: findings on gadolinium-enhanced MRI. J Magn Reson Imaging 2004, 20(5):838-842.
58. Kanematsu M., Goshima S., Kondo H., et al. Double hepatic arterial phase MRI of the liver with switching of reversed centric and centric K-space reordering. AJR Am J Roentgenol 2006, 187(2):464-472.
59. Mori K., Yoshioka H., Takahashi N., et al. Triple arterial phase dynamic MRI with sensitivity encoding for hypervascular hepatocellular carcinoma: comparison of the diagnostic accuracy among the early, middle, late, and whole triple arterial phase imaging. AJR Am J Roentgenol 2005, 184(1):63-69.
60. Yoshioka H., Takahashi N., Yamaguchi M., et al. Double arterial phase dynamic MRI with sensitivity encoding (SENSE) for hypervascular hepatocellular carcinomas. J Magn Reson Imaging 2002, 16(3):259-266.
61. Rohrer M., Bauer H., Mintorovitch J., et al. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol 2005, 40(11):715-724.
62. Vogl T.J., Kummel S., Hammerstingl R., et al. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. Radiology 1996, 200(1):59-67.
63. Spinazzi A., Lorusso V., Pirovano G., et al. Safety, tolerance, biodistribution, and MR imaging enhancement of the liver with gadobenate dimeglumine: results of clinical pharmacologic and pilot imaging studies in nonpatient and patient volunteers. Acad Radiol 1999, 6(5):282-291.
64. Spinazzi A., Lorusso V., Pirovano G., et al. Multihance clinical pharmacology: biodistribution and MR enhancement of the liver. Acad Radiol 1998, 5(Suppl 1):S86-S89. [discussion: S84-93].
65. Huppertz A., Haraida S., Kraus A., et al. Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT-initial observations. Radiology 2005, 234(2):468-478.
66. Zech C.J., Grazioli L., Breuer J., et al. Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance imaging: results of a multicenter trial. Invest Radiol 2008, 43(7):504-511.
67. Zech C.J., Herrmann K.A., Reiser M.F., et al. MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent Gd-EOB-DTPA. Magn Reson Med Sci 2007, 6(1):43-52.
68. Brismar T.B., Dahlstrom N., Edsborg N., et al. Liver vessel enhancement by Gd-BOPTA and Gd-EOB-DTPA: a comparison in healthy volunteers. Acta Radiol 2009, 50(7):709-715.
69. Tamada T., Ito K., Sone T., et al. Dynamic contrast-enhanced magnetic resonance imaging of abdominal solid organ and major vessel: comparison of enhancement effect between Gd-EOB-DTPA and Gd-DTPA. J Magn Reson Imaging 2009, 29(3):636-640.
70. Akai H., Kiryu S., Takao H., et al. Efficacy of double-arterial phase gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced liver magnetic resonance imaging compared with double-arterial phase multi-detector row helical computed tomography. J Comput Assist Tomogr 2009, 33(6):887-892.
71. Motosugi U., Ichikawa T., Sou H., et al. Dilution method of gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI). J Magn Reson Imaging 2009, 30(4):849-854.
72. Zech C.J., Vos B., Nordell A., et al. Vascular enhancement in early dynamic liver MR imaging in an animal model: comparison of two injection regimen and two different doses Gd-EOB-DTPA (gadoxetic acid) with standard Gd-DTPA. Invest Radiol 2009, 44(6):305-310.
73. Kuhn J.P., Hegenscheid K., Siegmund W., et al. Normal dynamic MRI enhancement patterns of the upper abdominal organs: gadoxetic acid compared with gadobutrol. AJR Am J Roentgenol 2009, 193(5):1318-1323.
74. Choi J.S., Kim M.J., Choi J.Y., et al. Diffusion-weighted MR imaging of liver on 3.0-Tesla system: effect of intravenous administration of gadoxetic acid disodium. Eur Radiol 2010, 20(5):1052-1060.
75. Kim Y.K., Kwak H.S., Kim C.S., et al. Detection and characterization of focal hepatic tumors: a comparison of T2-weighted MR images before and after the administration of gadoxetic acid. J Magn Reson Imaging 2009, 30(2):437-443.
76. Gulani V., Willatt J.M., Blaimer M., et al. Effect of contrast media on single-shot echo planar imaging: implications for abdominal diffusion imaging. J Magn Reson Imaging 2009, 30(5):1203-1208.
77. Motosugi U., Ichikawa T., Tominaga L., et al. Delay before the hepatocyte phase of Gd-EOB-DTPA-enhanced MR imaging: is it possible to shorten the examination time?. Eur Radiol 2009, 19(11):2623-2629.
78. Qayyum A. Diffusion-weighted imaging in the abdomen and pelvis: concepts and applications. Radiographics 2009, 29(6):1797-1810.
79. Parikh T., Drew S.J., Lee V.S., et al. Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging. Radiology 2008, 246(3):812-822.
80. Bruegel M., Holzapfel K., Gaa J., et al. Characterization of focal liver lesions by ADC measurements using a respiratory triggered diffusion-weighted single-shot echo-planar MR imaging technique. Eur Radiol 2008, 18(3):477-485.
81. Erturk S.M., Ichikawa T., Sano K., et al. Diffusion-weighted magnetic resonance imaging for characterization of focal liver masses: impact of parallel imaging (SENSE) and b value. J Comput Assist Tomogr 2008, 32(6):865-871.
82. Holzapfel K., Bruegel M., Eiber M., et al. Characterization of small (
83. Kilickesmez O., Bayramoglu S., Inci E., et al. Value of apparent diffusion coefficient measurement for discrimination of focal benign and malignant hepatic masses. J Med Imaging Radiat Oncol 2009, 53(1):50-55.
84. Sandrasegaran K., Akisik F.M., Lin C., et al. The value of diffusion-weighted imaging in characterizing focal liver masses. Acad Radiol 2009, 16(10):1208-1214.
85. Taouli B., Tolia A.J., Losada M., et al. Diffusion-weighted MRI for quantification of liver fibrosis: preliminary experience. Am J Roentgenol 2007, 189(4):799-806.
86. Luciani A., Vignaud A., Cavet M., et al. Liver cirrhosis: intravoxel incoherent motion MR imaging-pilot study. Radiology 2008, 249(3):891-899.
87. Nasu K., Kuroki Y., Sekiguchi R., et al. The effect of simultaneous use of respiratory triggering in diffusion-weighted imaging of the liver. Magn Reson Med Sci 2006, 5(3):129-136.
88. Taouli B., Sandberg A., Stemmer A., et al. Diffusion-weighted imaging of the liver: comparison of navigator triggered and breathhold acquisitions. J Magn Reson Imaging 2009, 30(3):561-568.
89. Kwee T.C., Takahara T., Koh D.M., et al. Comparison and reproducibility of ADC measurements in breathhold, respiratory triggered, and free-breathing diffusion-weighted MR imaging of the liver. J Magn Reson Imaging 2008, 28(5):1141-1148.
90. Deng J., Miller F.H., Salem R., et al. Multishot diffusion-weighted PROPELLER magnetic resonance imaging of the abdomen. Invest Radiol 2006, 41(10):769-775.
91. Huang J., Raman S.S., Vuong N., et al. Utility of breath-hold fast-recovery fast spin-echo T2 versus respiratory-triggered fast spin-echo T2 in clinical hepatic imaging. Am J Roentgenol 2005, 184(3):842-846.
92. Tang Y., Yamashita Y., Namimoto T., et al. Liver T2-weighted MR imaging: comparison of fast and conventional half-Fourier single-shot turbo spin-echo, breath-hold turbo spin-echo, and respiratory-triggered turbo spin-echo sequences. Radiology 1997, 203(3):766-772.
93. Coates G.G., Borrello J.A., McFarland E.G., et al. Hepatic T2-weighted MRI: a prospective comparison of sequences, including breath-hold, half-Fourier turbo spin echo (HASTE). J Magn Reson Imaging 1998, 8(3):642-649.
94. Lee M.G., Jeong Y.K., Kim J.C., et al. Fast T2-weighted liver MR imaging: comparison among breath-hold turbo-spin-echo, HASTE, and inversion recovery (IR) HASTE sequences. Abdom Imaging 2000, 25(1):93-99.
95. Katayama M., Masui T., Kobayashi S., et al. Fat-suppressed T2-weighted MRI of the liver: comparison of respiratory-triggered fast spin-echo, breath-hold single-shot fast spin-echo, and breath-hold fast-recovery fast spin-echo sequences. J Magn Reson Imaging 2001, 14(4):439-449.
96. Kim B.S., Kim J.H., Choi G.M., et al. Comparison of three free-breathing T2-weighted MRI sequences in the evaluation of focal liver lesions. J Am J Roentgenol 2008, 190(1):W19-27.